HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

azacyclonol

major descriptor (65-84); on-line search PIPERIDINES (65-84); Index Medicus search AZACYCLONOL (65-84); RN given refers to parent cpd

Also Known As:

azacyclonol hydrochloride

Networked: 9 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - azacyclonol: 9

Experts

1.	Banskota, Suhrid: 1 article (10/2018)
2.	Chaudhary, Prakash: 1 article (10/2018)
3.	Dahal, Sadan: 1 article (10/2018)
4.	Gautam, Jaya: 1 article (10/2018)
5.	Jeong, Byeong-Seon: 1 article (10/2018)
6.	Kang, Han-Eol: 1 article (10/2018)
7.	Kim, Dong-Guk: 1 article (10/2018)
8.	Kim, Jung-Ae: 1 article (10/2018)
9.	Lee, Iyn-Hyang: 1 article (10/2018)
10.	Nam, Tae-Gyu: 1 article (10/2018)

Related Diseases

1.	Schizophrenia (Dementia Praecox) 09/28/1957 - "Azacyclonol (frenquel) hydrochloride in the treatment of chronic schizophrenia; a double-blind, controlled study." 09/01/1959 - "Azacyclonol in chronic schizophrenia." 09/01/1958 - "Azacyclonol (frenquel) in chronic schizophrenia; objective measurement of its effects." 07/01/1956 - "Azacyclonol: use of a new pharmacologic agent in chronic schizophrenia."
2.	Lung Neoplasms (Lung Cancer) 10/01/2018 - "Overall, the present study showed that BJ-1207, a vitamin B6-derived 2,4,5-trimethylpyridin-3-ol compound with azacyclonol moiety at C (6)-position of the pyridine ring, inhibited NOX activity and that it is a promising lead compound for developing anticancer drugs against lung cancer."
3.	B-Cell Lymphoma (Lymphoma, B Cell) 01/01/2022 - "The clinical data of 31 patients with AML/MDS who were clearly diagnosed with AML/MDS were analyzed from 2018.10 to 2021.02, and the total amount of azacyclonol and B-cell lymphoma/leukemia-2 inhibitor was used for single or combined chemotherapy, with a total amount of 75 mg/m2 ∗7 d, divided into 7-10 days of continuous subcutaneous injection, every 28-30 days for a course of treatment. "
4.	Leukemia 01/01/2022 - "The clinical data of 31 patients with AML/MDS who were clearly diagnosed with AML/MDS were analyzed from 2018.10 to 2021.02, and the total amount of azacyclonol and B-cell lymphoma/leukemia-2 inhibitor was used for single or combined chemotherapy, with a total amount of 75 mg/m2 ∗7 d, divided into 7-10 days of continuous subcutaneous injection, every 28-30 days for a course of treatment. "
5.	Hallucinations (Hallucination) 03/01/1957 - "Failure of azacyclonol (frenquel) to relieve non-experimental mental confusion and hallucinations."

Related Drugs and Biologics

1.	Vitamins
2.	pyridine
3.	2,4,5-trimethylpyridin-3-ol

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Subcutaneous Injections